Cranial aspergillosis in a patient receiving ibrutinib for chronic lymphocytic leukemia

被引：10
|
作者：
Beresford, Rohan [1 ]
Dolot, Virginia [1 ]
Foo, Hong [1 ,2 ]
机构：
[1] NSW Hlth Pathol South West Sydney, Dept Microbiol & Infect Dis, Sydney, NSW, Australia
[2] Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia
来源：
MEDICAL MYCOLOGY CASE REPORTS | 2019年 / 24卷
关键词：
Aspergillosis; Ibrutinib; Cerebral abscess; Chronic lymphocytic leukemia;
D O I：
10.1016/j.mmcr.2019.02.005
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Cerebral abscess due to Aspergillus species is a relatively uncommon presentation, even amongst immunocompromised patients. However it is increasingly being recognized as a complication of ibrutinib therapy in patients with chronic lymphocytic leukemia. We present a case of cerebral abscesses caused by Aspergillus felis in a patient receiving ibrutinib for chronic lymphocytic leukemia.
引用
收藏
页码：27 / 29
页数：3
相关论文
共 50 条
  • [1] Cerebral aspergillosis: An emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia?
    Gaye, E.
    Le Bot, A.
    Talarmin, J. P.
    Le Calloch, R.
    Belaz, S.
    Dupont, M.
    Tattevin, P.
    MEDECINE ET MALADIES INFECTIEUSES, 2018, 48 (04): : 294 - 297
  • [2] Isolated central nervous system Aspergillosis infection in a chronic lymphocytic leukemia patient on Ibrutinib: A case report
    Le, Thuy-Hong
    Kumar, Vikas
    Gondal, Khubaib
    Barnes, Martin
    Siddique, Haseeb
    Buttar, Barjinder
    Kaell, Alan
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [3] Isolated central nervous system Aspergillosis infection in a chronic lymphocytic leukemia patient on Ibrutinib: A case report
    Thuy-Hong Le
    Vikas Kumar
    Khubaib Gondal
    Martin Barnes
    Haseeb Siddique
    Barjinder Buttar
    Alan Kaell
    BMC Infectious Diseases, 20
  • [4] Pharmacokinetics of ibrutinib in a patient with chronic lymphocytic leukemia on hemodialysis
    Ohtani, Toyoji
    Tani, Akiko
    Namme, Yuki
    Namme, Rie
    Hirose, Maki
    Shingu, Ikuo
    Kizawa, Yusuke
    Endo, Akira
    Yasu, Takeo
    CLINICAL NEPHROLOGY, 2022, 98 (06) : 301 - 304
  • [5] Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy
    Serhat Çelik
    Leylagül Kaynar
    Zeynep Tuğba Güven
    Mustafa Baydar
    Muzaffer Keklik
    Mustafa Çetin
    Ali Ünal
    Fatih Demirkan
    Indian Journal of Hematology and Blood Transfusion, 2022, 38 : 282 - 289
  • [6] Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy
    celik, Serhat
    Kaynar, Leylagul
    Guven, Zeynep Tugba
    Baydar, Mustafa
    Keklik, Muzaffer
    cetin, Mustafa
    Unal, Ali
    Demirkan, Fatih
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2022, 38 (02) : 282 - 289
  • [7] A case of CNS aspergillosis in a patient with chronic lymphocytic leukemia on first-line ibrutinib therapy
    Eichenberger, Emily M.
    Saullo, Jennifer
    Brander, Danielle
    Wang, Shih-Hsiu
    Perfect, John R.
    Messina, Julia A.
    MEDICAL MYCOLOGY CASE REPORTS, 2020, 27 : 17 - 21
  • [8] EXPERIENCE OF IBRUTINIB THERAPY IN THE TREATMENT OF PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Kurkina, N. V.
    Repina, E. A.
    Mashnina, N. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2017, 62 (01): : 55 - 56
  • [9] Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib
    Sittig, Katherine R.
    Laageide, Leah G.
    Akhtar, Zaheer
    Wall, Geoffrey C.
    Kumar, Sudhir C.
    IDCASES, 2021, 24
  • [10] Ibrutinib for the treatment of chronic lymphocytic leukemia
    Deodato, Marina
    Frustaci, Anna Maria
    Zamprogna, Giulia
    Cairoli, Roberto
    Montillo, Marco
    Tedeschi, Alessandra
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (05) : 273 - 284
12345